Optimization of spleen VCTE examinations with FibroSca
- Conditions
- Liver disease - Portal Hypertension10019654
- Registration Number
- NL-OMON53533
- Lead Sponsor
- Echosens
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 125
Inclusion Criteria
1. Adult or pediatric patient able to give written informed consent
(parents/legal tutors in case of minor patients),
2. Patient affiliated to the healthcare system,
3. Adult or children patient followed for a liver disease, with or without
splenomegaly and having a spleen to skin distance (SSD) measurement performed
during the screening ultrasound exam.
Exclusion Criteria
1. Vulnerable patient- other than pediatric patients
2. Patients with ascites
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Success rate of the spleen stiffness measurement (SSM) exam with the XL probe,<br /><br>defined with at least 8 valid measurements after the post-processing phase.</p><br>
- Secondary Outcome Measures
Name Time Method <p>1. Success rate of the SSM exam with the S probe, defined with at least 8 valid<br /><br>measurements after the post-processing phase.<br /><br>2. Success rate of the SSM exam with the optimized M probe, defined with at<br /><br>least 8 valid measurements after the post-processing phase.<br /><br>3. Improvement of the applicability with the STT and the automatic depth<br /><br>adaptation mode enabled.</p><br>